Compare BMY & PDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMY | PDD |
|---|---|---|
| Founded | 1887 | 2015 |
| Country | United States | Ireland |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.3B | 134.5B |
| IPO Year | N/A | 2018 |
| Metric | BMY | PDD |
|---|---|---|
| Price | $57.26 | $85.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 9 |
| Target Price | $61.73 | ★ $139.22 |
| AVG Volume (30 Days) | 8.9M | ★ 9.4M |
| Earning Date | 04-30-2026 | 05-26-2026 |
| Dividend Yield | ★ 4.38% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.35 |
| Revenue Next Year | N/A | $12.63 |
| P/E Ratio | $17.26 | ★ $10.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $81.56 |
| 52 Week High | $62.89 | $139.41 |
| Indicator | BMY | PDD |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 36.80 |
| Support Level | $56.36 | $81.56 |
| Resistance Level | $60.50 | $106.47 |
| Average True Range (ATR) | 1.40 | 2.83 |
| MACD | -0.08 | -0.71 |
| Stochastic Oscillator | 50.58 | 21.62 |
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
PDD Holdings operates commerce businesses in over 80 countries globally. Its main operations are Pinduoduo, a social commerce platform in China, and Temu, a global e-commerce marketplace. PDD also has a community group purchase business in China. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.